Advertisement
Screener

REGENXBIO Inc. (RGNX) Material Contracts

REGENXBIO Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-06: Form 10-Q; Exhibit 10.1; Description First Amendment to Loan Agreement dated April 28, 2026 between REGENXBIO RS LLC and affiliate of Healthcare Royalty Management, LLC.
  • 2026-05-14: Form 10-Q; Exhibit 10.2; Description License Agreement dated August 16, 2018 between the Registrant and Emory University.
  • 2026-05-14: Form 10-Q; Exhibit 10.1; Description Settlement and Release Agreement dated March 18, 2026 between the Registrant and GlaxoSmithKline LLC.
  • 2025-11-06: Form 10-Q; Exhibit 10.1; Description First Amendment to Collaboration and License Agreement dated September 10, 2021 between the Registrant and AbbVie Global Enterprises Ltd..
FiledFormExhibitDescription
2026-08-0610-Q10.1First Amendment to Loan Agreement dated April 28, 2026 between REGENXBIO RS LLC and affiliate of Healthcare Royalty Management, LLC
2026-05-1410-Q10.2License Agreement dated August 16, 2018 between the Registrant and Emory University
2026-05-1410-Q10.1Settlement and Release Agreement dated March 18, 2026 between the Registrant and GlaxoSmithKline LLC
2025-11-0610-Q10.1First Amendment to Collaboration and License Agreement dated September 10, 2021 between the Registrant and AbbVie Global Enterprises Ltd.
2025-08-0710-Q10.4Loan Agreement dated May 16, 2025 between REGENXBIO RS LLC and affiliate of HealthCare Royalty Management, LLC
2025-08-0710-Q10.3Form of Stock Option Award Agreement for the 2025 Equity Incentive Plan
2025-08-0710-Q10.2Form of Restricted Stock Unit Award Agreement for the 2025 Equity Incentive Plan
2025-05-1210-Q10.1Collaboration and License Agreement dated January 14, 2025 between the Registrant and Nippon Shinyaku Co., Ltd.
2024-11-0610-Q10.2Consulting Agreement, effective as of September 16, 2024, between the Registrant and Vittal Vasista
2024-11-0610-Q10.1Employment Separation Agreement, effective as of September 21, 2024, between the Registrant and Vittal Vasista
2024-08-0110-Q10.2Consulting and Employment Separation Agreement effective as of July 1, 2024 between the Registrant and Kenneth T. Mills
2024-08-0110-Q10.1Employment Agreement effective as of July 1, 2024 between the Registrant and Curran Simpson
2024-02-2710-K10.9Form of Employment Agreement for Executive Vice Presidents
2022-08-0310-Q10.1Compensation Program for Non-Employee Directors
2022-05-0410-Q10.1Letter Agreement dated March 21, 2022 between the Company and The Trustees of the University of Pennsylvania
2022-03-0110-K10.40Settlement Agreement and Mutual Release dated November 12, 2021 between the Registrant and Abeona Therapeutics Inc.
2021-11-0210-Q10.1Collaboration and License Agreement dated September 10, 2021 between the Company and AbbVie Global Enterprises Ltd.
2021-03-0110-K10.42Royalty Purchase Agreement dated December 22, 2020 between the Registrant and entities managed by Healthcare Royalty Management, LLC
2021-03-0110-K10.5Form of Stock Option Award Agreement for the 2015 Equity Incentive Plan
2021-03-0110-K10.4Form of Restricted Stock Unit Award Agreement for the 2015 Equity Incentive Plan
2020-11-0410-Q10.4Third Amendment to Lease dated October 30, 2020 between the Company and ARE-Maryland No. 24, LLC
2020-11-0410-Q10.3Fifth Amendment to Lease dated October 30, 2020 between the Company and ARE-Maryland No. 45, LLC
2020-11-0410-Q10.2Fifth Amendment to License Agreement effective September 11, 2020 between the Company and The Trustees of the University of Pennsylvania
2020-11-0410-Q10.1Compensation Program for Non-Employee Directors
2020-02-2610-K10.23First Amendment to License Agreement dated November 4, 2019 between the Registrant and Abeona Therapeutics Inc.
2020-02-2610-K10.11Compensation Program for Non-Employee Directors
2019-11-0510-Q10.1Second Amendment to Lease dated November 4, 2019 between the Company and ARE-Maryland No. 24, LLC
2019-08-0710-Q10.1Compensation Program for Non-Employee Directors
2019-06-038-K10.2First Amendment to Lease dated May 28, 2019 between REGENXBIO Inc. and DS400OWNER, LLC.
2019-06-038-K10.1Lease dated May 16, 2016 between REGENXBIO Inc. and DS400OWNER, LLC, as successor-in-interest to 400 Madison Holdings, LLC.
2019-05-0710-Q10.4First Amendment to Lease dated April 23, 2019 between the Company and ARE-Maryland No. 24, LLC
2019-05-0710-Q10.3Letter Agreement to Lease dated April 12, 2019 between the Company and ARE-Maryland No. 24, LLC
2019-05-0710-Q10.2Fourth Amendment to License Agreement effective April 4, 2019 between the Company and The Trustees of the University of Pennsylvania
2019-05-0710-Q10.1Employment Agreement effective April 17, 2019 between the Company and Steve Pakola, M.D.
2019-02-2710-K10.22License Agreement dated November 4, 2018 between the Registrant and Abeona Therapeutics Inc.
2019-02-2710-K10.12Compensation Program for Non-Employee Directors
2018-11-0710-Q10.1Lease dated November 1, 2018 between the Company and ARE-Maryland No. 24, LLC
2018-05-0810-Q10.1Fourth Amendment to Lease dated April 20, 2018 between the Registrant and BMR-Medical Center Drive LLC
2018-03-0610-K10.24First Amendment to License Agreement dated January 8, 2018 between the Registrant and AveXis, Inc.
2018-02-018-K/A10.1Separation Agreement and General Release, dated January 26, 2018, between the Company and Faraz Ali.
2017-11-0810-Q10.1First Amendment to Lease dated November 3, 2017 between the Company and 9600 Blackwell II LLC, as successor in interest to TNREF III 9600 Blackwell, LLC
2017-08-0810-Q10.1Third Amendment to Lease dated July 21, 2017 between the Registrant and BMR-Medical Center Drive LLC
2017-05-0910-Q10.1Employment Agreement effective as of March 27, 2017 between the Registrant and Olivier Danos, Ph.D.
2017-03-0710-K10.20First Amendment to Exclusive Patent License Agreement dated November 28, 2016 between the Registrant and the Regents of the University of Minnesota
2016-12-2310-Q/A10.36Third Amendment to License Agreement effective April 29, 2016 between the Registrant and The Trustees of the University of Pennsylvania
2016-11-0910-Q10.37Employment Agreement effective as of August 18, 2016 between the Registrant and Patrick J. Christmas
2016-08-0910-Q10.36Third Amendment to License Agreement effective April 29, 2016 between the Registrant and The Trustees of the University of Pennsylvania
2016-05-0510-Q10.35Employment Agreement effective as of February 29, 2016 between the Registrant and Faraz Ali
2016-03-0310-K10.34Employment Agreement effective as of February 16, 2016 between the Registrant and Curran Simpson
2016-03-0310-K10.33Lease dated January 28, 2016 between the Registrant and TNREF III 9600 Blackwell, LLC
2016-03-0310-K10.32Second Amendment to Lease dated November 23, 2015 between the Registrant and BMR-Medical Center Drive LLC
2016-03-0310-K10.31First Amendment to Lease dated September 30, 2015 between the Registrant and BMR-Medical Center Drive LLC

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B